IMT-HALT Trademark

Trademark Overview


On Friday, March 26, 2021, a trademark application was filed for IMT-HALT with the United States Patent and Trademark Office. The USPTO has given the IMT-HALT trademark a serial number of 90606612. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 5, 2022. This trademark is owned by ImmunoMolecular Therapeutics, LLC. The IMT-HALT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Custom design, development and optimization of new drug molecules, chemical reagents and biochemical assays; scientific and technological services, namely, custom design and development of new chemical and biological molecules with drug-like properties, in silico computations of molecular interactions, modulation of human leukocyte antigens (HLA) proteins in the field of disease such as autoimmunity; pharmaceutical research and development; scientific research for medical and drug development purposes in the fields of immunotherapy, autoimmune diseases and disorders; development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research services; research in the field of pharmaceuticals for the treatment of immunological diseases and disorders; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
imt-halt

General Information


Serial Number90606612
Word MarkIMT-HALT
Filing DateFriday, March 26, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 5, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2021

Trademark Statements


Goods and ServicesCustom design, development and optimization of new drug molecules, chemical reagents and biochemical assays; scientific and technological services, namely, custom design and development of new chemical and biological molecules with drug-like properties, in silico computations of molecular interactions, modulation of human leukocyte antigens (HLA) proteins in the field of disease such as autoimmunity; pharmaceutical research and development; scientific research for medical and drug development purposes in the fields of immunotherapy, autoimmune diseases and disorders; development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research services; research in the field of pharmaceuticals for the treatment of immunological diseases and disorders; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 2, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmunoMolecular Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWoburn, MA 01801

Party NameImmunoMolecular Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWoburn, MA 01801

Trademark Events


Event DateEvent Description
Tuesday, September 6, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 5, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 7, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 3, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, November 3, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 3, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, November 3, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 3, 2021ASSIGNED TO EXAMINER
Friday, July 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 30, 2021NEW APPLICATION ENTERED IN TRAM